Activity Overview | This Webcast contains video and downloadable slides from our symposium “Evolving Strategies in the Management of Advanced Ovarian Cancer,” a prIME Oncology educational activity that was held after the official ESMO program hours on Monday, 11 October in Milan, Italy. |
Faculty | Chairman:
Stanley Kaye, MD, FRCP
The Royal Marsden Hospital & Institute of Cancer Research
Sutton, United Kingdom
Faculty:
Robert A. Burger, MD, FACOG, FACS
Fox Chase Cancer Center
Philadelphia, Pennsylvania, USA
Nicoletta Colombo, MD
University of Milan-Bicocca
Milan, Italy
Andres Poveda, MD
Fundacion Instituto Valenciano
de Oncologia
Valencia, Spain
|
Target Audience | This educational activity is designed for gynecologic oncologists, medical oncologists, and other healthcare professionals involved and/or interested in the management of patients with ovarian cancer. |
|
|
 |
|
Expert Discussion
|
 |
|
Downloadable Slides
|
|
 |
Topics |
|
Topic 1
|
Defining the rationale and role for targeted therapy in ovarian cancer
Nicoletta Colombo, MD
|
|
Topic 2
|
Targeting angiogenesis: Where are we in 2010?
Robert A. Burger, MD, FACOG, FACS
|
|
Topic 3
|
Beyond antiangiogenesis: What are the options?
Andres Poveda, MD
|
|
|
Learning Objectives | After successful completion of this educational activity, participants should be able to:
- Discuss currently available management strategies for patients with ovarian cancer and the unmet need for new therapeutic options within this patient population
- Define the rationale for various molecular targets as they apply to the management of advance ovarian cancer
- Evaluate data from recent clinical trials involving the use of targeted therapies in the management of patients with epithelial ovarian cancer
|
|
|
|
Support |
Financial support for this activity
has been provided by
F. Hoffmann-La Roche Ltd.
|
|
